This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Europe Viscosupplementation Market

Market Insights on Europe Viscosupplementation covering sales outlook, demand forecast & up-to-date key trends

Europe Viscosupplementation Market By Product Type (Single Injection Viscosupplementation, Three Injection Viscosupplementation, Five Injection Viscosupplementation), End User (Hospitals, Ambulatory Surgical Centres, Orthopaedic Clinics) & Region - Forecast to 2016-2026

Introduction

Rising prevalence of knee osteoarthritis is fuelling demand for effective treatment therapies. Hyaluronic acid-based intra-articular injections have proved to be one of the most preferred choices of treatment for symptomatic knee osteoarthritis. Hyaluronic acid-based intra-articular injections restore normal viscoelastic properties of altered synovial fluid in the knee joint, delivering effective therapeutic effect. The ultimate goal of viscosupplementation is to increase the concentration of hyaluronate in the joints so to restore the altered synovial fluid present in the joints.

Growing prevalence of osteoarthritis, strong healthcare infrastructure and well established reimbursements are soaring the demand for viscosupplementation market. The Europe viscosupplementation market has been segmented by product type, end user and region.

Customize this Report

Let us know your requirement to get
100% FREE customization

Market Value and Forecast

The Europe viscosupplementation market has been estimated to be valued at US$ 192.0 Mn in 2015 and is expected to expand at a CAGR of 5.1% over the forecast period (2016–2026).

Market Dynamics

Growth of the Europe viscosupplementation market is mainly driven by rising obesity rates and growing patient awareness about effective treatment therapies for knee osteoarthritis, coupled with macroeconomic factors such as high unmet patient needs and strengthening of distribution network by key players in the viscosupplementation market. Other prominent growth drivers include rapidly growing medical technology industry and cost-effectiveness of the treatment. However, economic issues in some Eastern European countries and reimbursement cutbacks are expected to hamper overall growth of the viscosupplementation market in Europe over the forecast period.

Viscosupplementation devices are classified under Class III category in Europe and are considered high-risk devices. They require premarket approval from notified bodies, including private organisations recognised by the European Free Trade Association (EFTA).

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Market Segmentation By Product

Based on product type, the market has been segmented into single injection viscosupplementation, three injection viscosupplementation and five injection viscosupplementation.

Europe Viscosupplementation Market Download Report Brochure

Single injection viscosupplementation product type segment is expected to exhibit the highest growth over the forecast period.

Market Segmentation By End User

Based on end users, the market has been segmented into hospitals, ambulatory surgical centres and orthopaedic clinics. Hospitals segment currently accounts for the highest revenue share in the Europe viscosupplementation market. Orthopaedic clinics segment is also gaining prominence in Europe due to upcoming attractive reimbursement options and patient preference for single injection cycle over multiple injection cycle treatment.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Key Regions

The Europe viscosupplementation market has been segmented into Western Europe and Eastern Europe. In terms of value, Western Europe has been estimated to dominate the Europe viscosupplementation market in 2015 and is expected to expand at a CAGR of 5.1% over the forecast period. In Eastern Europe, effective formalisation of patient registries are gaining prominence. This could lead to better patient diagnosis and enhance access to treatments. In addition to this, reimbursement policies in the region are in the process of being formalised in accordance with guidelines developed by both local and national pricing authorities.

Key Players

Some key players in the global infusion pumps market identified in this report are Anika Therapeutics Inc., Sanofi S.A., Zimmer Biomet Holdings, Meda AB, Ferring B.V, Fidia Pharmaceutici S.p.A, and Bioventus LLC. The report also identifies company-specific strategies related to product development, market consolidation initiatives and analysis of their specific strengths, weaknesses, opportunities and threats.

Key Segments

  • Product Type
    • Single Injection Viscosupplementation
    • Three Injection Viscosupplementation
    • Five Injection Viscosupplementation
  • End User
    • Hospitals
    • Ambulatory Surgical Centres
    • Orthopaedic Clinics

 Key Regions/Countries

  • Western Europe
    • U.K.
    • France
    • Germany
    • Spain
    • Italy
    • Nordics
    • Rest of Western Europe
  • Eastern Europe
    • Russia
    • Rest of Eastern Europe

Frequently Asked Questions

The Europe visco supplementation market is predicted to grow at 9.37% CAGR through 2032.

Europe visco supplementation market holds the highest revenue potential.

The Europe visco supplementation market is expected to surpass US$ 11 Bn by 2032.

The Europe visco supplementation market size is anticipated to be over US$ 4.5 Bn in 2022.

Table of Content

1. Research Methodology

2. Assumptions and Acronyms Used

3. Executive Summary

4. Viscosupplementation Market Overview 

4.1. Viscosupplementation Market Definition & Taxonomy

4.2. Europe Viscosupplementation Market Forecast, 2016-2026

4.2.1. Introduction

4.2.2. Market Value Forecast and Y-o-Y Growth Rate, (2016-2026)

4.3. Europe Viscosupplementation Market Dynamics 

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunity 

4.3.4. Trends

4.4. Europe Viscosupplementation Market, Drug Pipelines and Key Players 

4.5. Europe Viscosupplementation Market Regulatory Guidelines

4.6. Europe Viscosupplementation Market Reimbursement Scenario

5. Europe Viscosupplementation Market Forecast, By Product Type 

5.1. Introduction

5.2. Y-o-Y Growth Comparison By Product Type 

5.3. Market Share & Basis Point (BPS) Analysis By Product Type 

5.3.1. Single Injection Viscosupplementation Market Value

5.3.2. Three Injection Viscosupplementation Market Value

5.3.3. Five Injection Viscosupplementation Market Value

5.4. Europe Viscosupplementation Market Attractive Analysis By Product Type 

6. Europe Viscosupplementation Market Forecast, By End Use

6.1. Introduction

6.2. Y-o-Y Growth Comparison By End Use 

6.3. Market Share & Basis Point (BPS) Analysis By End Use

6.3.1. Hospitals Market Value

6.3.2. Ambulatory Surgical Centers Market Value

6.3.3. Orthopedic Clinics Market Value

6.4. Europe Viscosupplementation Market Attractive Analysis By End Use

7. Europe Viscosupplementation Market Forecast, By Region

7.1. Introduction

7.2. Y-o-Y Growth Comparison By Region 

7.3. Market Share & Basis Point (BPS) Analysis By Region

7.3.1. Western Europe Market Value

7.3.2. Eastern Europe Surgical Centers Market Value

7.4. Europe Viscosupplementation Market Attractive Analysis By Region 

8. Western Europe Viscosupplementation Market Analysis

8.1. Introduction 

8.2. Y-o-Y Growth Projections, By Country

8.3. Market Share & Basis Point (BPS) Analysis, By Country

8.4. Western Europe Viscosupplementation Market Forecast 

8.4.1. Western Europe Viscosupplementation Market Value Forecast, By Country

8.4.1.1. Germany Absolute $ Opportunity

8.4.1.2. France Absolute $ Opportunity

8.4.1.3. U.K. Absolute $ Opportunity

8.5.1.4. Spain Absolute $ Opportunity

8.6.1.5. Italy Absolute $ Opportunity

8.7.1.6. Nordic Absolute $ Opportunity

8.8.1.7. Rest of Western Europe Absolute $ Opportunity 

8.4.2. Western Europe Viscosupplementation Market Value Forecast, By Product Type

8.4.2.1. Single Injection Viscosupplementation

8.4.2.2. Three Injection Viscosupplementation

8.4.2.3. Five Injection Viscosupplementation

8.4.3. Western Europe Viscosupplementation Market Value Forecast, By End User  

8.4.3.1. Hospitals

8.4.3.2. Ambulatory Surgical Centers

8.4.3.3. Orthopedic Clinics 

8.5. Western Europe Viscosupplementation Market Attractiveness Analysis 

8.5.1. By Country

8.5.2. By Product Type

8.5.3. By End User 

8.5.4. By Country  

8.6. Drivers & Restraints: Impact Analysis

9. Eastern Europe Viscosupplementation Market Analysis

9.1. Introduction 

9.2. Y-o-Y Growth Projections, By Country

9.3. Market Share & Basis Point (BPS) Analysis, By Country

9.4. Eastern Europe Viscosupplementation Market Forecast 

9.4.1. Eastern Europe Viscosupplementation Market Value Forecast, By Country

9.4.1.1. Russia Absolute $ Opportunity

9.4.1.2. Rest of Eastern Europe Absolute $ Opportunity

9.4.2. Eastern Europe Viscosupplementation Market Value Forecast, By Product 

9.4.2.1. Single Injection Viscosupplementation

9.4.2.2. Three Injection Viscosupplementation

9.4.2.3. Five Injection Viscosupplementation

9.4.3 Eastern Europe Viscosupplementation Market Value Forecast, By End User  

9.4.3.1. Hospitals

9.4.3.2. Ambulatory Surgical Centers

9.4.3.3. Orthopedic Clinics 

9.5. Eastern Europe Viscosupplementation Market Attractiveness Analysis 

9.5.1. By Country

9.5.2. By Product Type

9.5.3. By End User 

9.5.4. By Country  

9.6. Drivers & Restraints: Impact Analysis

10. Competition Landscape 

10.1. Competition Dashboard

10.2. Company Profiles 

10.2.1. Revenue

10.2.2. Products/Brand Offerings

10.2.3. Key developments

10.2.4. SWOT Analysis 

10.3. Company Highlights 

10.3.1. Anika Therapeutics, Inc.

10.3.2. Fidia Farmaceutici s.p.a.

10.3.3. Sanofi

10.3.4. Ferring B.V

10.3.5. Meda AB

10.3.6. Zimmer Biomet Holdings Inc

10.3.7. Bioventus LLC.

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Europe Viscosupplementation Market Value Forecast (US$ Mn), 2014–2026

Figure 2: Europe Viscosupplementation Market Absolute $ Opportunity, 2014–2026

Figure 3: Europe Viscosupplementation Market Scenario Forecast, 2016–2026

Figure 4: Europe Viscosupplementation Market Value Share, by Product Type, 2015 & 2026

Figure 5: Europe Viscosupplementation Y-o-Y Growth, by Product Type, 2015–2026

Figure 6: Europe Viscosupplementation Market Value Forecast (US$ Mn), by Single Injection Viscosupplementation Product Type, 2014–2026

Figure 7: Europe Viscosupplementation Market Absolute $ Opportunity, by Single Injection Viscosupplementation Product Type, 2014–2026

Figure 8: Europe Viscosupplementation Market Value Forecast (US$ Mn), by Three Injection Viscosupplementation Product Type, 2014–2026

Figure 9: Europe Viscosupplementation Market Absolute $ Opportunity, by Three Injection Viscosupplementation Product Type, 2014–2026

Figure 10: Europe Viscosupplementation Market Value Forecast (US$ Mn), by Five Injection Viscosupplementation Product Type, 2014–2026

Figure 11: Europe Viscosupplementation Market Absolute $ Opportunity, by Five Injection Viscosupplementation Product Type, 2014–2026

Figure 12: Europe Viscosupplementation Market Attractiveness Analysis, by Product Type, 2015–2026

Figure 13: Europe Viscosupplementation Market Value Share, by End-use, 2015 & 2026

Figure 14: Europe Viscosupplementation Market Y-o-Y Growth Rate, by End-use, 2015–2026

Figure 15: Europe Viscosupplementation Market Value Forecast (US$ Mn), by Hospitals End-use Segment, 2014–2026

Figure 16: Europe Viscosupplementation Market Absolute $ Opportunity, by Hospitals End-use Segment, 2014–2026

Figure 17: Europe Viscosupplementation Market Value Forecast (US$ Mn), by Ambulatory Surgical Centres End-use Segment, 2014–2026

Figure 18: Europe Viscosupplementation Market Absolute $ Opportunity, by Ambulatory Surgical Centres End-use Segment, 2014–2026

Figure 19: Europe Viscosupplementation Market Value Forecast (US$ Mn), by Orthopediac Clinics End-use Segment 2014–2026

Figure 20: Europe Viscosupplementation Market Absolute $ Opportunity, by Orthopediac Clinics End-use Segment, 2014–2026

Figure 21: Europe Viscosupplementation Market Attractiveness Analysis, by End-use, 2015–2026

Figure 22: Europe Viscosupplementation Market Value Share, by Region, 2015 & 2026

Figure 23: Europe Viscosupplementation Y-o-Y Growth Rate, by Region, 2015–2026

Figure 24: Western Europe Viscosupplementation Market Value Forecast (US$ Mn), 2014–2026

Figure 25: Western Europe Viscosupplementation Market Absolute $ Opportunity, 2014–2026

Figure 26: Eastern Europe Viscosupplementation Market Value Forecast (US$ Mn), 2014–2026

Figure 27: Eastern Europe Viscosupplementation Market Absolute $ Opportunity, 2014–2026

Figure 28: Europe Viscosupplementation Market Attractiveness Analysis, by Region, 2015–2026

Figure 29: Western Europe Viscosupplementation Y-o-Y Growth, by Country, 2015–2026

Figure 30: Western Europe Viscosupplementation Market Value Share, by Country, 2015 & 2026

Figure 31: Germany Viscosupplementation Market Value Forecast (US$ Mn), 2014–2026

Figure 32: Germany Viscosupplementation Market Absolute $ Opportunity, 2014–2026

Figure 33: U.K. Viscosupplementation Market Value Forecast (US$ Mn), 2014–2026

Figure 34: U.K. Viscosupplementation Market Absolute $ Opportunity, 2014–2026

Figure 35: France Viscosupplementation Market Value Forecast (US$ Mn), 2014–2026

Figure 36: France Viscosupplementation Market Absolute $ Opportunity, by 2014–2026

Figure 37: Italy Viscosupplementation Market Value Forecast (US$ Mn), 2014–2026

Figure 38: Italy Viscosupplementation Market Absolute $ Opportunity, 2014–2026

Figure 39: Spain Viscosupplementation Market Value Forecast (US$ Mn), 2014–2026

Figure 40: Spain Viscosupplementation Market Absolute $ Opportunity, 2014–2026

Figure 41: Nordic Viscosupplementation Market Value Forecast (US$ Mn), 2014–2026

Figure 42: Nordic Viscosupplementation Market Absolute $ Opportunity, 2014–2026

Figure 43: Rest of Western Europe Viscosupplementation Market Value Forecast (US$ Mn), 2014–2026

Figure 44: Rest of Western Europe Viscosupplementation Market Absolute $ Opportunity, 2014–2026

Figure 45: Western Europe Viscosupplementation Market Attractiveness Analysis, by Country, 2015–2026

Figure 46: Western Europe Viscosupplementation Market Attractiveness Analysis, by Product Type, 2015–2026

Figure 47: Western Europe Viscosupplementation Market Attractiveness Analysis, by End-use, 2015–2026

Figure 48: Eastern Europe Viscosupplementation Y-o-Y Growth, by Country, 2015–2026

Figure 49: Eastern Europe Viscosupplementation Market Value Share, by Country, 2015 & 2026

Figure 50: Russia Viscosupplementation Market Value Forecast (US$ Mn), 2014–2026

Figure 51: Russia Viscosupplementation Market Absolute $ Opportunity, 2014–2026

Figure 52: Rest of Eastern Europe Viscosupplementation Market Value Forecast (US$ Mn), 2014–2026

Figure 53: Rest of Eastern Europe Viscosupplementation Market Absolute $ Opportunity, 2014–2026

Figure 54: Eastern Europe Viscosupplementation Market Attractiveness Analysis, by Country, 2015–2026

Figure 55: Eastern Europe Viscosupplementation Market Attractiveness Analysis, by Product Type, 2015–2026

Figure 56: Eastern Europe Viscosupplementation Market Attractiveness Analysis, by End-use, 2015–2026

Figure 57: Germany Viscosupplementation Market- Company Share Analysis (%), By Single Injection Viscosupplementation, 2015

Figure 58: Germany Viscosupplementation Market- Company Share Analysis (%), By Three Injection Viscosupplementation, 2015

Figure 59: Germany Viscosupplementation Market- Company Share Analysis (%), By Five Injection Viscosupplementation, 2015

Figure 60: U.K. Viscosupplementation Market- Company Share Analysis (%), By Single Injection Viscosupplementation, 2015

Figure 61: U.K. Viscosupplementation Market- Company Share Analysis (%), By Three Injection Viscosupplementation, 2015

Figure 62: U.K. Viscosupplementation Market- Company Share Analysis (%), By Five Injection Viscosupplementation, 2015

Figure 63: France Viscosupplementation Market- Company Share Analysis (%), By Single Injection Viscosupplementation, 2015

Figure 64: France Viscosupplementation Market- Company Share Analysis (%), By Three Injection Viscosupplementation, 2015

Figure 65: France Viscosupplementation Market- Company Share Analysis (%), By Five Injection Viscosupplementation, 2015

Figure 66: Italy Viscosupplementation Market- Company Share Analysis (%), By Single Injection Viscosupplementation, 2015

Figure 67: Italy Viscosupplementation Market- Company Share Analysis (%), By Three Injection Viscosupplementation, 2015

Figure 68: Italy Viscosupplementation Market- Company Share Analysis (%), By Five Injection Viscosupplementation, 2015

Figure 69: Spain Viscosupplementation Market- Company Share Analysis (%), By Single Injection Viscosupplementation, 2015

Figure 70: Spain Viscosupplementation Market- Company Share Analysis (%), By Three Injection Viscosupplementation, 2015

Figure 71: Spain Viscosupplementation Market- Company Share Analysis (%), By Five Injection Viscosupplementation, 2015

Figure 72: Nordic Viscosupplementation Market- Company Share Analysis (%), By Single Injection Viscosupplementation, 2015

Figure 73: Nordic Viscosupplementation Market- Company Share Analysis (%), By Three Injection Viscosupplementation, 2015

Figure 74: Nordic Viscosupplementation Market- Company Share Analysis (%), By Five Injection Viscosupplementation, 2015

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Europe Viscosupplementation Market